Biomarkers in prostate cancer: what's new?
DA Sartori, DW Chan - Current opinion in oncology, 2014 - journals.lww.com
Several new tests, as discussed in this review, have become available during the last 2
years. Although the intended use of most of these tests is to distinguish PCa from benign …
years. Although the intended use of most of these tests is to distinguish PCa from benign …
Epigenome-wide association studies without the need for cell-type composition
In epigenome-wide association studies, cell-type composition often differs between cases
and controls, yielding associations that simply tag cell type rather than reveal fundamental …
and controls, yielding associations that simply tag cell type rather than reveal fundamental …
An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform
The proper identification of differentially methylated CpGs is central in most epigenetic
studies. The Illumina HumanMethylation450 BeadChip is widely used to quantify DNA …
studies. The Illumina HumanMethylation450 BeadChip is widely used to quantify DNA …
Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory
JL García-Giménez, M Seco-Cervera… - Critical reviews in …, 2017 - Taylor & Francis
Epigenetic modifications and regulators represent potential molecular elements which
control relevant physiological and pathological features, thereby contributing to the natural …
control relevant physiological and pathological features, thereby contributing to the natural …
Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation
GH Rauscher, JK Kresovich, M Poulin, L Yan, V Macias… - BMC cancer, 2015 - Springer
Background Breast cancer formation is associated with frequent changes in DNA
methylation but the extent of very early alterations in DNA methylation and the biological …
methylation but the extent of very early alterations in DNA methylation and the biological …
Aberrant methylation patterns in cancer: a clinical view
A Videtic Paska, P Hudler - Biochemia medica, 2015 - hrcak.srce.hr
Sažetak Epigenetic mechanisms, such as DNA methylation, DNA hydroxymethylation, post-
translational modifications (PTMs) of histone proteins affecting nucleosome remodelling …
translational modifications (PTMs) of histone proteins affecting nucleosome remodelling …
SOX9: The master regulator of cell fate in breast cancer
S Jana, BM Krishna, J Singhal, D Horne… - Biochemical …, 2020 - Elsevier
SRY-related high-mobility group box 9 (SOX9) is an indispensable transcription factor that
regulates multiple developmental pathways related to stemness, differentiation, and …
regulates multiple developmental pathways related to stemness, differentiation, and …
Epigenetic mechanisms in bone
P Vrtačnik, J Marc, B Ostanek - Clinical Chemistry and Laboratory …, 2014 - degruyter.com
Epigenetics refers to the study of mechanisms able to influence gene expression in a stable
and potentially heritable manner without altering the DNA sequence. These mechanisms …
and potentially heritable manner without altering the DNA sequence. These mechanisms …
Epigenetic effects of green tea polyphenols in cancer
SM Henning, P Wang, CL Carpenter, D Heber - Epigenomics, 2013 - Taylor & Francis
Epigenetics describes heritable alterations of gene expression and chromatin organization
without changes in DNA sequence. Both hypermethylation and hypomethylation of DNA can …
without changes in DNA sequence. Both hypermethylation and hypomethylation of DNA can …